BioGeometry Raises $100 Million to Scale AI Models That Design Drugs From Scratch

On average, it takes about 10-15 years to produce a new drug. Artificial intelligence could rewrite how new drugs are discovered as BioGeometry raises $100 million. The Beijing-based startup closed

— Ventureburn
Read the full story on Ventureburn

This story was written and published by Ventureburn. Business.co.za shows its headline and teaser from the publisher’s RSS feed and links to the original.

What business people are saying

0

No comments yet. Be the first.

More in Startups & SMEs

All →